CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

HC Wainwright Initiates Immuneering at Buy With $14 Price Target

Positive
AI Analysis

Summary

HC Wainwright initiated coverage of Immuneering with a Buy rating and $14 price target.

Importance:2/10
Sentiment:
0.70
analyst_ratingprice_targetequity_research
Related Companies

Read the original article

Published by yahoo_finance on August 6, 2026 11:18 AM

Read Original